Class II · Moderate risk Terminated
Imipramine Pamoate Capsules 125 mg
Reason Out of specification result observed in a dissolution test at the 9-month long term stability time point.
Imipramine HCL
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Labeling: Label Mixup: IMIPRAMINE HCL, Tablet, 25 mg may have potentially been mislabeled as the following drug: FENOFIBRATE, Tablet, 54 mg, NDC 00115551110, Pedigree: AD49448_7, EXP: 5/17/2014.
What was recalled
IMIPRAMINE HCL, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781176401.
- Recalling firm
- Aidapak Services, LLC
- Origin
- WA, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-1002-2014
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Other Imipramine recalls
See all
Class III · Low risk Terminated
Imipramine HCl Tablets
Reason Chemical Contamination; benzophenone leached from the product label varnish
Class III · Low risk Terminated
Imipramine HCl Tablets
Reason Chemical Contamination; benzophenone leached from the product label varnish
Class III · Low risk Terminated
Imipramine HCl Tablets
Reason Chemical Contamination; benzophenone leached from the product label varnish
Get an alert if your medication is recalled
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.